The phosphoinositide 3′-kinase p110δ modulates contractile protein production and IL-6 release in human airway smooth muscle

Journal of Cellular Physiology

Volumn 227, Issue 8, 2012, Pages 3044-3052

  Ge, Qi ^a,b   Moir, Lyn M ^a,b   Trian, Thomas ^a   Niimi, Kyoko ^a   Poniris, Maree ^a,b   Shepherd, Peter R ^c   Black, Judith L ^a,b   Oliver, Brian G ^a,b   Burgess, Janette K ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CRC for Asthma and Airways   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

2 (6 AMINO 9 PURINYLMETHYL) 5 METHYL 3 (2 METHYLPHENYL) 3H QUINAZOLIN 4 ONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; 9 (1 ANILINOETHYL) 7 METHYL 2 MORPHOLINOPYRIDO[1,2 A]PYRIMIDIN 4 ONE; ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; INTERLEUKIN 6; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 4 (5 BENZO(1,3)DIOXOL 5 YL 4 PYRIDIN 2 YL 1H IMIDAZOL 2 YL)BENZAMIDE; 4-(5-BENZO(1,3)DIOXOL-5-YL-4-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE; ADENINE; BENZAMIDE DERIVATIVE; CHROMONE DERIVATIVE; CONTRACTILE PROTEIN; DRUG DERIVATIVE; MORPHOLINE DERIVATIVE; PIK3CD PROTEIN, HUMAN; QUINAZOLINE DERIVATIVE; TGFB1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASTHMA; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; CELL CULTURE; CYTOLOGY; DONOR; GENE EXPRESSION REGULATION; GENETICS; LUNG; METABOLISM; MIDDLE AGED; PATHOLOGY; SMOOTH MUSCLE;

ADENINE; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; BENZAMIDES; CELLS, CULTURED; CHROMONES; CONTRACTILE PROTEINS; DIOXOLES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; LUNG; MALE; MIDDLE AGED; MORPHOLINES; MUSCLE, SMOOTH; PHOSPHATIDYLINOSITOL 3-KINASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUINAZOLINES; TISSUE DONORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84860476142     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23046     Document Type: Article

References (54)

1. Ali K, Bilancio A, Thomas M, Pearce W, Gilfillan AM, Tkaczyk C, Kuehn N, Gray A, Giddings J, Peskett E, Fox R, Bruce I, Walker C, Sawyer C, Okkenhaug K, Finan P, Vanhaesebroeck B. 2004. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 431: 1007-1011.
2. Ali K, Camps M, Pearce WP, Ji H, Ruckle T, Kuehn N, Pasquali C, Chabert C, Rommel C, Vanhaesebroeck B. 2008. Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo. J Immunol 180: 2538-2544.
3. Ammit AJ, Moir LM, Oliver BG, Hughes JM, Alkhouri H, Ge Q, Burgess JK, Black JL, Roth M. 2007. Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 292: L199-L206.
4. Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. 2003. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 167: 1360-1368.
5. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. 2006. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61: 17-22.
6. Burgess JK, Oliver BG, Poniris MH, Ge Q, Boustany S, Cox N, Moir LM, Johnson PR, Black JL. 2006. A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro. J Allergy Clin Immunol 118: 649-657.
7. Burgess JK, Lee JH, Ge Q, Ramsay EE, Poniris MH, Parmentier J, Roth M, Johnson PR, Hunt NH, Black JL, Ammit AJ. 2008. Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: Differences in asthma. J Cell Physiol 216: 673-679.
8. Burgler S, Ouaked N, Bassin C, Basinski TM, Mantel PY, Siegmund K, Meyer N, Akdis CA, Schmidt-Weber CB. 2009. Differentiation and functional analysis of human T(H)17cells. J Allergy Clin Immunol 123: 588-595, 595 e581-587.
9. Chambers RC, Leoni P, Kaminski N, Laurent GJ, Heller RA. 2003. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 162: 533-546.
10. Chaussade C, Rewcastle GW, Kendall JD, Denny WA, Cho K, Gronning LM, Chong ML, Anagnostou SH, Jackson SP, Daniele N, Shepherd PR. 2007. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem J 404: 449-458.
11. Condliffe AM, Davidson K, Anderson KE, Ellson CD, Crabbe T, Okkenhaug K, Vanhaesebroeck B, Turner M, Webb L, Wymann MP, Hirsch E, Ruckle T, Camps M, Rommel C, Jackson SP, Chilvers ER, Stephens LR, Hawkins PT. 2005. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 106: 1432-1440.
12. Cruse G, Cockerill S, Bradding P. 2008. IgE alone promotes human lung mast cell survival through the autocrine production of IL-6. BMC Immunol 9: 2-9.
13. de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, van Krieken JH. 1998. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158: 1951-1957.
14. Farghaly HS, Blagbrough IS, Medina-Tato DA, Watson ML. 2008. Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110delta-dependent mechanism. Mol Pharmacol 73: 1530-1537.
15. Finan PM, Thomas MJ. 2004. PI 3-kinase inhibition: A therapeutic target for respiratory disease. Biochem Soc Trans 32: 378-382.
16. Foukas LC, Berenjeno IM, Gray A, Khwaja A, Vanhaesebroeck B. 2010. Activity of any class IA PI3K isoform can sustain cell proliferation and survival. Proc Natl Acad Sci USA 107: 11381-11386.
17. Fujii T, Takagi H, Arimoto M, Ootani H, Ueeda T. 2000. Bundle formation of smooth muscle desmin intermediate filaments by calponin and its binding site on the desmin molecule. J Biochem 127: 457-465.
18. Gamell C, Osses N, Bartrons R, Ruckle T, Camps M, Rosa JL, Ventura F. 2008. BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity. J Cell Sci 121: 3960-3970.
19. Ge Q, Moir LM, Black JL, Oliver BG, Burgess JK. 2010. TGFbeta1 induces IL-6 and inhibits IL-8 release in human bronchial epithelial cells: The role of Smad2/3. J Cell Physiol 225: 846-854.
20. Gimona M, Kaverina I, Resch GP, Vignal E, Burgstaller G. 2003. Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Mol Biol Cell 14: 2482-2491.
21. Goldsmith AM, Bentley JK, Zhou L, Jia Y, Bitar KN, Fingar DC, Hershenson MB. 2006. Transforming growth factor-beta induces airway smooth muscle hypertrophy. Am J Respir Cell Mol Biol 34: 247-254.
22. Gu L, Zhu YJ, Yang X, Guo ZJ, Xu WB, Tian XL. 2007. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation. Acta Pharmacol Sin 28: 382-391.
23. Halayko AJ, Kartha S, Stelmack GL, McConville J, Tam J, Camoretti-Mercado B, Forsythe SM, Hershenson MB, Solway J. 2004. Phophatidylinositol-3 kinase/mammalian target of rapamycin/p70S6K regulates contractile protein accumulation in airway myocyte differentiation. Am J Respir Cell Mol Biol 31: 266-275.
24. Hooshmand-Rad R, Hajkova L, Klint P, Karlsson R, Vanhaesebroeck B, Claesson-Welsh L, Heldin CH. 2000. The PI 3-kinase isoforms p110(alpha) and p110(beta) have differential roles in PDGF- and insulin-mediated signaling. J Cell Sci 113: 207-214.
25. Ivison SM, Khan MA, Graham NR, Shobab LA, Yao Y, Kifayet A, Sly LM, Steiner TS. 2010. The p110alpha and p110beta isoforms of class I phosphatidylinositol 3-kinase are involved in toll-like receptor 5 signaling in epithelial cells. Mediators Inflamm 652098: 1-12.
26. Jamieson S, Flanagan JU, Kolekar S, Buchanan C, Kendall JD, Lee WJ, Rewcastle GW, Denny WA, Singh R, Dickson J, Baguley BC, Shepherd PR. 2011. A drug targeting only p110alpha can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types. Biochem J 438: 53-62.
27. Je HD, Gangopadhyay SS, Ashworth TD, Morgan KG. 2001. Calponin is required for agonist-induced signal transduction-Evidence from an antisense approach in ferret smooth muscle. J Physiol 537: 567-577.
28. Johnson PR, Roth M, Tamm M, Hughes M, Ge Q, King G, Burgess JK, Black JL. 2001. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 164: 474-477.
29. Johnson PR, Burgess JK, Ge Q, Poniris M, Boustany S, Twigg SM, Black JL. 2006. Connective tissue growth factor induces extracellular matrix in asthmatic airway smooth muscle. Am J Respir Crit Care Med 173: 32-41.
30. Kaplan-Albuquerque N, Garat C, Desseva C, Jones PL, Nemenoff RA. 2003. Platelet-derived growth factor-BB-mediated activation of Akt suppresses smooth muscle-specific gene expression through inhibition of mitogen-activated protein kinase and redistribution of serum response factor. J Biol Chem 278: 39830-39838.
31. Kim HR, Gallant C, Leavis PC, Gunst SJ, Morgan KG. 2008. Cytoskeletal remodeling in differentiated vascular smooth muscle is actin isoform dependent and stimulus dependent. Am J Physiol Cell Physiol 295: C768-C778.
32. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B, Balla T, Weiss WA, Williams RL, Shokat KM. 2006. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125: 733-747.
33. Krymskaya VP, Ammit AJ, Hoffman RK, Eszterhas AJ, Panettieri RA, Jr. 2001. Activation of class IA PI3K stimulates DNA synthesis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 280: L1009-L1018.
34. Lee KS, Lee HK, Hayflick JS, Lee YC, Puri KD. 2006. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J 20: 455-465.
35. Marwick JA, Caramori G, Casolari P, Mazzoni F, Kirkham PA, Adcock IM, Chung KF, Papi A. 2010a. A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 125: 1146-1153.
36. Marwick JA, Chung KF, Adcock IM. 2010b. Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease. Ther Adv Respir Dis 4: 19-34.
37. Michaeloudes C, Sukkar MB, Khorasani NM, Bhavsar PK, Chung KF. 2010. TGF-{beta} regulates Nox4, MnSOD and catalase expression and IL-6 release in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 300: L295-L304.
38. Moir LM, Trian T, Ge Q, Shepherd PR, Burgess JK, Oliver BG, Black JL. 2011. PI 3-Kinase isoform specific effects in airway mesenchymal cell function. J Pharmacol Exp Ther 337: 557-566.
39. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, Pinsky DJ, Watkins SC, Pilewski JM, Sciurba FC, Peters DG, Hogg JC, Choi AM. 2004. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 101: 14895-14900.
40. North AJ, Gimona M, Cross RA, Small JV. 1994a. Calponin is localised in both the contractile apparatus and the cytoskeleton of smooth muscle cells. J Cell Sci 107: 437-444.
41. North AJ, Gimona M, Lando Z, Small JV. 1994b. Actin isoform compartments in chicken gizzard smooth muscle cells. J Cell Sci 107: 445-455.
42. Northcott CA, Hayflick JS, Watts SW. 2004. PI3-kinase upregulation and involvement in spontaneous tone in arteries from DOCA-salt rats: Is p110delta the culprit? Hypertension 43: 885-890.
43. Okamoto M, Takeda K, Joetham A, Han J, Gelfand EW. 2009. IL-6 from dendritic cells regulates airway hyperresponsiveness and inflammation by controlling the fate of CD4+ T cells. Am J Respir Crit Care Med 179: A5463.
44. Sadhu C, Dick K, Tino WT, Staunton DE. 2003a. Selective role of PI3K delta in neutrophil inflammatory responses. Biochem Biophys Res Commun 308: 764-769.
45. Sadhu C, Masinovsky B, Dick K, Sowell CG, Staunton DE. 2003b. Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J Immunol 170: 2647-2654.
46. Sagara H, Okada T, Okumura K, Ogawa H, Ra C, Fukuda T, Nakao A. 2002. Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma. J allergy Clin Immunol 110: 249-254.
47. Springer J, Scholz FR, Peiser C, Groneberg DA, Fischer A. 2004. SMAD-signaling in chronic obstructive pulmonary disease: Transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke. Biol Chem 385: 649-653.
48. Tang Y, Urs S, Boucher J, Bernaiche T, Venkatesh D, Spicer DB, Vary CP, Liaw L. 2010. Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem 285: 17556-17563.
49. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P. 1999. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 159: 487-494.
50. Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, la Rocca AM, Bellia V, Bonsignore G, Bousquet J. 1997. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 156: 591-599.
51. Wicks J, Haitchi HM, Holgate ST, Davies DE, Powell RM. 2006. Enhanced upregulation of smooth muscle related transcripts by TGF beta2 in asthmatic (myo) fibroblasts. Thorax 61: 313-319.
52. Winder SJ, Walsh MP. 1990. Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation. J Biol Chem 265: 10148-10155.
53. Xie S, Sukkar MB, Issa R, Khorasani NM, Chung KF. 2007. Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta. Am J Physiol Lung Cell Mol Physiol 293: L245-L253.
54. Xie S, Macedo P, Hew M, Nassenstein C, Lee KY, Chung KF. 2009. Expression of transforming growth factor-beta (TGF-beta) in chronic idiopathic cough. Respir Res 10: 40-49.